Home / Inspections / 963627

FDA Inspection 963627 — AstraZeneca Pharmaceuticals, LP

AstraZeneca Pharmaceuticals, LP — FEI 3010199915

The FDA completed an inspection of AstraZeneca Pharmaceuticals, LP on March 29, 2016 in Coppell, TX. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 29, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Coppell, TX (United States)

Facility

Other inspections at this facility

  • 1312298 (NAI Fri Apr 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1047488 (NAI Mon Mar 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 998797 (OAI Mon Jan 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 954660 (NAI Fri Dec 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources